Ahmet Gul
Overview
Explore the profile of Ahmet Gul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
253
Citations
5026
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gul A, Langford C
Rheumatology (Oxford)
. 2025 Mar;
64(Supplement_1):i120-i122.
PMID: 40071406
Systemic vasculitis can present with different manifestations, some of which require unique approaches. This session at the 21st International Vasculitis Workshop, examined six studies focused on "Management of Special Situations"....
2.
Erdem Y, Ozkaya E, Erbilgin Y, Saritas M, Sayitoglu M, Su Kucuk O, et al.
Dermatitis
. 2025 Jan;
PMID: 39772616
No abstract available.
3.
Hacisuleyman A, Gul A, Erman B
Proteins
. 2024 Dec;
PMID: 39739522
This study presents a novel method to assess the pathogenicity of pyrin protein mutations by using mutual information (MI) as a measure to quantify the correlation between residue motions or...
4.
Bektas M, Celik B, Ince B, Yalcinkaya Y, Esen B, Gul A, et al.
Reumatologia
. 2024 Dec;
62(5):330-337.
PMID: 39677873
Introduction: Psoriatic arthritis (PsA) is a heterogeneous disease with various manifestations such as dactylitis, enthesitis, spondylitis, and skin involvement. Minimal disease activity (MDA) has been successfully used in daily clinical...
5.
Amikishiyev S, Yalcinkaya Y, Mammadova K, Aliyeva N, Durak G, Artim-Esen B, et al.
Mod Rheumatol
. 2024 Oct;
PMID: 39417276
Objectives: We aimed to analyze the prevalence, mortality, and prognostic factors in systemic sclerosis (SSc) patients with pulmonary hypertension (PH) with or without interstitial lung disease (ILD). Methods: The associations...
6.
Bektas E, Buyukdemir A, Yalcinkaya Y, Esen B, Inanc M, Gul A
Clin Exp Rheumatol
. 2024 Oct;
42(10):2071-2075.
PMID: 39404478
Objectives: Inflammatory endothelial activation is a prominent feature of vascular involvement in Behçet's disease (BD), which is usually accompanied by a thrombotic tendency. Recent studies suggest an association between ABO...
7.
Deniz R, Emrence Z, Punar S, Ileri B, Arga K, Alibaz-Oner F, et al.
J Clin Rheumatol
. 2024 Oct;
30(8):e178-e184.
PMID: 39353077
Objectives: Behçet disease (BD) has heterogeneous presentations, mainly mucocutaneous, vascular, and ocular manifestations. The mechanisms associated with different phenotypes have not been clarified. We aimed to investigate the expression of...
8.
Mirioglu S, Cinar S, Uludag O, Gurel E, Varelci S, Ozluk Y, et al.
Turk J Med Sci
. 2024 Jul;
54(2):391-400.
PMID: 39050398
Background/aim: In this prospective study, we aimed to investigate the association of serum (s) and urine (u) IP-10, galectin-9, and SIGLEC-1 with disease activity in patients with systemic lupus erythematosus...
9.
Yalcinkaya Y, Esen B, Amikishiyev S, Aliyeva N, Gul A, Ocal L, et al.
Turk J Med Sci
. 2024 May;
53(6):1704-1712.
PMID: 38813512
Background/aim: B-cell depletion with rituximab (RTX) is widely used as a rescue therapy in patients with systemic sclerosis (SSc). The aim herein was to analyze the progress of disease-related outcomes...
10.
Uludag O, Cinar S, McDonnell T, Cene E, Yalcinkaya Y, Gul A, et al.
Turk J Med Sci
. 2024 May;
53(5):1067-1074.
PMID: 38813003
Background/aim: In this cross-sectional study, it was aimed to test the predictive value of noncriteria antiphospholipid antibodies (aPL) in addition to the global antiphospholipid syndrome score (GAPSS) in predicting vascular...